{"database": "lobbying", "table": "lobbying_activities", "rows": [[1931509, "b9b03bff-3d4f-4635-a591-a0fbdbbd15a5", "Q4", "BAY BRIDGE STRATEGIES, INC.", 312190, "BIOCRYST PHARMACEUTICALS, INC.", 2016, "fourth_quarter", "DIS", "Issues related to pandemic preparedness and biodefense. Ebola response.", "SENATE", 20000, null, 0, 0, "2017-01-23T10:23:45-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1931509"], "units": {}, "query_ms": 25.030449964106083, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}